Who we are

Esaote VET is the veterinary division of Esaote Group, which is currently one of the world’s leading manufacturers of diagnostic imaging systems. In the veterinary field, we have a global market share of more than 50%.

For more than 30 years, our company has conducted extensive research to develop innovative technologies specifically designed to meet the clinical needs of veterinary practices, making us a leader in the field. We are committed to the continuous improvement and the growth of our community of professionals and experts.

Our commitment extends beyond the product itself: we provide support to operators at every stage of their journey, and our solutions are inspired by an open and direct dialogue with veterinarians, a relentless pursuit of excellence and a targeted approach to veterinary care.

We see our products as part of a larger system of support and relationships with our customers. In fact, we support our customers and scientific communities around the world by organizing professional development events and by bringing together a network of experts and opinion leaders. We invest in education and training activities, which we provide either directly or through qualified suppliers.

• 1982
  Esaote Born inside Ansaldo (IRI Finmeccanica Group), a state-owned company.

• 1983-1988
  Ansaldo internal division becomes part of EsaControl. This new company grew rapidly by merging with the Florence company OTE Biomedica.

• 1990s
  Esaote VET is established and a dedicated range of veterinary diagnostic equipment is launched.

• 1992
  Internationalisation process starts. First acquisition in the USA (Biosound).

• 1994
  Esaote becomes a private company through an innovative Management Buy-Out.

• 1996 - 2003
  Esaote was listed on the Milan Stock Exchange and the Nasdaq in New York, then delisted in 2003.

• 1998
  Esaote VET continues to grow with the acquisition of Pie Medical by Philips, with which Esaote further develops its ultrasound systems for veterinary use.

• 2002
  A new challenge: the first dedicated MRI system for veterinary applications is produced.

• 2009
  3^rd MBO with new investors: Ares Life Sciences – a private equity fund specialising in investments in the biomedical and healthcare sectors – acquired 40% of Esaote's share capital. The remaining 60% is still held by the same shareholders and by Esaote management.

• 2013 - 2017
  The production facilities in Genoa (Erzelli and Multedo) and Florence (Centro Eccellenza Sonde and HUB) are completely renovated and the organizational and business models are renewed.

• 2018
  Change of Esaote's ownership: the company acquired by a Consortium of leading Chinese investors. The Consortium is composed of major companies in the medical and healthcare technology sectors as well as investment funds with significant experience in this field.

• 2019 - 2022
  To cope with the new scenarios dictated by the pandemic, the e-shop, Esaote's new e-commerce, the Academy, and various digital initiatives dedicated to new talents and healthcare professionals are born.

• 2021 - 2022
  Esaote joined the UN Global Compact and reinforced its actions in the field of sustainability.

• 2023
  Esaote S.p.A. and Ebit s.r.l. have obtained the Gender Equality Certification in Italy. This confirms its commitment to the well-being of individuals and the creation of a serene and respectful work environment.